Highlights:
China MedTech Intelligence
News, Data and Industry Insights from China’s Medical Technology Market
October 14, 2026
85 Units Awarded in Public Tenders! China Surgical Robot Market Watch, Q3 2026
MedRobot’s Q3 2026 tally captures 85 surgical robot units awarded via public hospital tenders across China, totalling around RMB 537 million. Orthopaedic robots led by unit volume, laparoscopic systems dominated contract value, while neurosurgical awards remained concentrated among two domestic vendors. The dataset covers laparoscopic, orthopaedic, neurosurgical, dental, puncture and vascular interventional robots and tracks shifting hospital adoption patterns, with important caveats that tender awards are not equivalent to installed or clinically active systems.
October 9, 2026
Sequoia China Acquires Cardiovascular Device Upstream Supplier
Sequoia China has secured an 80% controlling stake in PeierTech, a veteran Chinese manufacturer of medical‑grade Nitinol alloy and contract manufacturing services for interventional medical devices. The deal represents the firm’s first controlling buyout focused on medical device upstream materials, highlighting growing investor interest in domestic supply chain resilience for cardiovascular and minimally invasive device segments.
September 17, 2026
Full Recap! The 4th Global Medical Robotics Conference
More than 600 clinicians, hospital managers, surgical robotics companies, researchers, investors and industry partners gathered in Beijing for the 4th Global Medical Robotics Conference, with two days of presentations and roundtables covering clinical application, product development, supply chains, overseas expansion, technology transfer, reimbursement and hospital adoption.
